SCHEMBL7469293

SCHEMBL7469293

CON1C(=O)SC(Cc2ccccc2)C1=O

nearest known ligand 0.56

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.56
KDM4E B2RXH2 1/20 0.56
PPARG P37231 4/20 0.46
MAOB P27338 1/20 0.45
CYP1A2 P05177 1/20 0.45
CYP3A4 P08684 1/20 0.45
CYP2D6 P10635 1/20 0.45
CYP2C9 P11712 1/20 0.45
CYP2C19 P33261 1/20 0.45
CA2 P00918 1/20 0.42
POLB P06746 1/20 0.41
LMNA P02545 6/20 0.40
KMT2A Q03164 3/20 0.38
MCL1 Q07820 1/20 0.38
MEN1 O00255 1/20 0.37
TSHR P16473 1/20 0.37
EP300 Q09472 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6032172 0.85 MAPT (0.53) MAPTKDM4EPPARGMAOBCYP1A2
SCHEMBL8486948 0.76 MAPT (0.44) MAPTKDM4EPPARGMAOBCYP1A2
SCHEMBL15503737 0.74 MAPT (0.81) MAPTKDM4EMAOBCYP1A2CYP3A4
SCHEMBL8687360 0.74 PPARG (0.48) MAPTKDM4EPPARGCYP1A2CYP3A4
SCHEMBL8523887 0.74 MAPT (0.43) MAPTKDM4EPPARGMAOBCYP1A2
SCHEMBL8484201 0.72 SIGMAR1 (0.45) MAPTKDM4E
SCHEMBL8659791 0.72 MAPT (0.44) MAPTKDM4EPPARGCYP1A2CYP3A4
SCHEMBL6037063 0.72 MAPT (0.52) MAPTKDM4EPPARGMAOBCYP1A2
SCHEMBL8660907 0.71 PPARG (0.53) MAPTKDM4EPPARGCYP1A2CYP3A4
SCHEMBL8472101 0.71 MAPT (0.41) MAPTKDM4EPPARGMAOBCYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1214305-A1 BENZYLIDENE-THIAZOLIDINEDIONES AND ANALOGUES AND THEIR USE IN THE TREATMENT OF INFLAMMATION Maxia Pharmaceuticals, Inc. (US) 2002-06-19 EP claimed
WO-2001016123-A1 BENZYLIDENE-THIAZOLIDINEDIONES AND ANALOGUES AND THEIR USE IN THE TREATMENT OF INFLAMMATION MAXIA PHARMACEUTICALS, INC. (US) 2001-03-08 WO claimed
EP-0804193-A4 THIAZOLIDINE DERIVATIVES FOR THE TREATMENT OF PSORIASIS KURTZ THEODORE W (US) 2002-03-27 EP disclosed
EP-0804193-A1 THIAZOLIDINE DERIVATIVES FOR THE TREATMENT OF PSORIASIS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 1997-11-05 EP disclosed
WO-1995035108-A1 THIAZOLIDINE DERIVATIVES FOR THE TREATMENT OF PSORIASIS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 1995-12-28 WO disclosed